ChronoScale Holdings (CHRN) Research & Development (2013 - 2026)

ChronoScale Holdings (CHRN) has reported Research & Development for 14 consecutive years, with $2.1 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Research & Development rose 20.15% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $7.5 million, a 4.42% increase from a year earlier, with the FY2025 full-year figure at $7.2 million, down 2.11% from the prior year.
• Research & Development was $2.1 million for Q1 2026 at ChronoScale Holdings, down from $2.4 million in the prior quarter.
• Over five years, Research & Development peaked at $2.4 million in Q4 2025 and troughed at $1.3 million in Q3 2025.
• A 5-year average of $1.9 million and a median of $1.9 million in 2024 frame the typical range for Research & Development.
• The widest YoY moves for Research & Development: up 29.72% in 2025, down 25.4% in 2025.
• Over 5 years, Research & Development stood at $1.9 million in 2022, then gained by 1.95% to $2.0 million in 2023, then decreased by 4.99% to $1.9 million in 2024, then grew by 29.72% to $2.4 million in 2025, then dropped by 16.08% to $2.1 million in 2026.
• The last three Research & Development figures came in at $2.1 million (Q1 2026), $2.4 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.